Literature DB >> 15148239

Macular infarction after intravitreal amikacin.

B H Doft, M Barza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15148239      PMCID： PMC1772176          DOI： 10.1136/bjo.2003.038885

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  2 in total

1.  Macular infarction after intravitreal amikacin: mounting evidence against amikacin.

Authors:  G Galloway; A Ramsay; K Jordan; A Vivian
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

2.  An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis.

Authors:  Alvin K H Kwok; Mamie Hui; Chi Pui Pang; Raphael C Y Chan; Siu Wai Cheung; Cynthia M S Yip; Dennis S C Lam; Augustine F B Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799
  2 in total
  2 in total

1.  Macular infarction after intravitreal amikacin: authors' reply.

Authors:  G D Galloway; A Ramsay; K Jordan; A Vivian
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

2.  Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!

Authors:  V Vedantham
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.